The global malaria diagnostics market size reached US$ 729.1 Million in 2021. Looking forward, the publisher expects the market to reach US$ 1,089.5 Million by 2027, exhibiting a CAGR of 6.92% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
Malaria Diagnostics Market Trends:
The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global malaria diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology and end use.Breakup by Technology:
- Microscopy
- Rapid Diagnostic Tests (RDTs)
- Molecular Diagnostic Tests
- Conventional PCR
- Real-Time PCR (qPCR)
Breakup by End Use:
- Hospital
- Clinics
- Diagnostic Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc.Key Questions Answered in This Report:
- How has the global malaria diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global malaria diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global malaria diagnostics market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Malaria Diagnostics Market
What is the estimated value of the Global Malaria Diagnostics Market?
What is the growth rate of the Global Malaria Diagnostics Market?
What is the forecasted size of the Global Malaria Diagnostics Market?
Who are the key companies in the Global Malaria Diagnostics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 144 |
| Published | August 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 729.1 Million |
| Forecasted Market Value ( USD | $ 1089.5 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Malaria Diagnostics Market
6 Market Breakup by Technology
7 Market Breakup by End Use
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Access Bio
- Beckman Coulter Inc. (Danaher Corporation)
- bioMérieux SA (Compagnie Merieux Alliance)
- Bio-Rad Laboratories Inc.
- Nikon Corporation
- Novartis AG
- Olympus Corporation
- Premier Medical Corporation Pvt. Ltd.
- Siemens Healthcare GmbH (Siemens AG)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
